no you really didnt explain anything with your Tesla example. Telsa is an eCAR manufacturer NWBO IS NOT a CDMO Do you understand the difference?
You stick with your opinion that CRL the go-to manufacturer for nonrevenue biotech with 21,400 employees 150 locations and $4 billion in revue is a loser and therefore its better to start your own CDMO from scratch, fine with me.
According to you, all biotech managers dont understand how to build a biotech except the brilliant LP. Heck, you have to justify something for the dilution that shareholders have been through in order to pay for Linda's private CDMO.